The Role of Surfactant in Respiratory Distress Syndrome

por Ma, Christopher Cheng-Hwa, Ma, Sze
Publicado 2012

Elagolix is porphyrogenic and may induce porphyric attacks in patients with the acute hepatic porphyrias

por Ma, Christopher D., Bonkovsky, Herbert L.
Publicado 2022

Eslicarbazepine acetate is porphyrogenic and should be used with caution in patients with the acute hepatic porphyrias

por Ma, Christopher D., Bonkovsky, Herbert L.
Publicado 2022

Colonic Dieulafoy's Lesion: A Rare Cause of Lower Gastrointestinal Hemorrhage and Review of Endoscopic Management

por Ma, Christopher, Hundal, Rajveer, Cheng, Edwin J.
Publicado 2014

Idiosyncratic drug-induced liver injury caused by givosiran in a patient with acute intermittent porphyria

por Ma, Christopher D., Faust, Denise, Bonkovsky, Herbert L.
Publicado 2022

Recurrent symptoms of acute intermittent porphyria after biochemical normalization with givosiran—An ongoing clinical conundrum

por Ma, Christopher D., Faust, Denise, Bonkovsky, Herbert L.
Publicado 2022

A review of the role of intermittent fasting in the management of inflammatory bowel disease

por Lavallee, Celeste M., Bruno, Andreina, Ma, Christopher, Raman, Maitreyi
Publicado 2023

Clinical utility of ustekinumab in Crohn’s disease

por Kotze, Paulo Gustavo, Ma, Christopher, Almutairdi, Abdulelah, Panaccione, Remo
Publicado 2018

The old versus the new: which do you keep in postoperative Crohn's disease?

por Kotze, Paulo Gustavo, Ma, Christopher, Regueiro, Miguel, Panaccione, Remo
Publicado 2018

The Role of Intermittent Fasting in the Management of Nonalcoholic Fatty Liver Disease: A Narrative Review

por Lavallee, Celeste M., Bruno, Andreina, Ma, Christopher, Raman, Maitreyi
Publicado 2022

An unsupervised learning approach to find ovarian cancer genes through integration of biological data

por Ma, Christopher, Chen, Yixin, Wilkins, Dawn, Chen, Xiang, Zhang, Jinghui
Publicado 2015

Systematic review: efficacy and safety of switching patients between reference and biosimilar infliximab

por Feagan, Brian G., Lam, Gordon, Ma, Christopher, Lichtenstein, Gary R.
Publicado 2018

Structural dynamics control the MicroRNA maturation pathway

por Dallaire, Paul, Tan, Huiping, Szulwach, Keith, Ma, Christopher, Jin, Peng, Major, François
Publicado 2016

Managing Inflammatory Bowel Disease During COVID-19: Summary of Recommendations from Gastrointestinal Societies

por Hanzel, Jurij, Ma, Christopher, Marshall, John K., Feagan, Brian G., Jairath, Vipul
Publicado 2020

Synthetic Chondramide A Analogues Stabilize Filamentous Actin and Block Invasion by Toxoplasma gondii

por Ma, Christopher I., Diraviyam, Karthikeyan, Maier, Martin E., Sept, David, Sibley, L. David
Publicado 2013

The Argument Against a Biosimilar Switch Policy for Infliximab in Patients with Inflammatory Bowel Disease Living in Alberta

por Kaplan, Gilaad G, Ma, Christopher, Seow, Cynthia H, Kroeker, Karen I, Panaccione, Remo
Publicado 2020

Fr099 HEALTHCARE PROVIDER SATISFACTION WITH VIRTUAL CARE DELIVERY IN ALBERTA DURING THE COVID-19 PANDEMIC.

por Olayinka, Lily, Kaplan, Gilaad, Ma, Christopher, Reeb, Leanne, Panaccione, Remo, Kroeker, Karen I.
Publicado 2021

Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic Porphyria: Design, Development, and Place in Therapy

por Majeed, Chaudry Nasir, Ma, Christopher D, Xiao, Ted, Rudnick, Sean, Bonkovsky, Herbert L
Publicado 2022

Assessment of porphyrogenicity of drugs and chemicals in selected hepatic cell culture models through a fluorescence‐based screening assay

por Ma, Christopher D., Van Horn, Cynthia G., Wan, Meimei, Bishop, Colin, Bonkovsky, Herbert L.
Publicado 2022

Matching-Adjusted Indirect Comparison Between Risankizumab and Ustekinumab for Induction and Maintenance Treatment of Moderately to Severely Active Crohn’s Disease

por Dubinsky, Marla, Ma, Christopher, Griffith, Jenny, Crowell, Marjorie, Neimark, Ezequiel, Kligys, Kristina, O’Connell, Tom
Publicado 2023